{"id":"W4413774125","doi":"10.1016/s2152-2650(25)00753-0","title":"POSTER: CML-754 Improved Patient-Reported Outcomes (PROs) With Asciminib vs Investigator-Selected Tyrosine Kinase Inhibitors (IS-TKIs) in Newly Diagnosed Chronic Myeloid Leukemia (CML): ASC4FIRST Week 48 PROs Analysis","year":2025,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Myeloid leukemia; Tyrosine kinase; Oncology; Internal medicine; Dasatinib; Imatinib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002635357,0.0006938947,0.001114398,0.0003305489,0.0003296024,0.001268256,0.0003957572,0.0008501374,0.02349112],"category_scores_gemma":[0.003029926,0.0002047971,0.003813146,0.0003461878,0.0003069042,0.0007457052,0.0006116996,0.002144624,0.002358464],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001052221,"about_ca_system_score_gemma":0.001074279,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008504287,"about_ca_topic_score_gemma":0.002169091,"domain_scores_codex":[0.9992216,0.0003769747,0.00004832693,0.00008674251,0.0001202925,0.0001460638],"domain_scores_gemma":[0.9984932,0.0004612995,0.0004184984,0.00007940042,0.0001383199,0.0004092837],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6820111,0.004123999,0.02345296,0.002139091,0.00839955,0.00009626771,0.00008379076,0.003420518,0.003063523,0.0009208159,0.06167832,0.21061],"study_design_scores_gemma":[0.3646316,0.2121645,0.3215016,0.001806647,0.02083556,0.0003835894,0.0003147086,0.004084737,0.006747347,0.002801456,0.06452279,0.0002055769],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8969693,0.01734202,0.001012848,0.01114916,0.002565363,0.002130824,0.04416491,0.000283129,0.02438243],"genre_scores_gemma":[0.9507797,0.005822049,0.001315225,0.005260407,0.001967469,0.001608323,0.01610333,0.00006550167,0.01707783],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02349112,"threshold_uncertainty_score":0.07858562,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01578916958822854,"score_gpt":0.2878932926959074,"score_spread":0.2721041231076788,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}